Install
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
- 158articles · 30d
- 2+ day agolatest article
- Aug 14, 2026earliest in window
- 94%with images
- 253avg words
- Health 158
- Medical 157
- Health & Wellness 153
- Business & Industrial 3
- Finance & Business 1
- Jobs & Education 1
- STEM 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Treatment Strategies for Biomarker-Negative and PI3K-Pathway Altered HR+/HER2??? mBC
2+ day, 21+ hour ago (207+ words) Aditya Bardia, MD, MPH, FASCO; Priya Kumar, MBBS, MS Aditya Bardia, MD, MPH, FASCO; Mohammad F. Ali, MD Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne S. Tsao, MD, MBA Kamel Abou Hussein, MD; Kate Baxstrom, MD Geoffrey…...
EU Approves T-DXd/Pertuzumab for Frontline HER2+ Metastatic Breast Cancer
1+ week, 3+ day ago (404+ words) The European Commission has approved T-DXd plus pertuzumab as first-line therapy for HER2-positive metastatic breast cancer based on DESTINY-Breast09. The approval follows a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency and…...